0001209191-23-021566.txt : 20230329
0001209191-23-021566.hdr.sgml : 20230329
20230329200011
ACCESSION NUMBER: 0001209191-23-021566
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230328
FILED AS OF DATE: 20230329
DATE AS OF CHANGE: 20230329
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Call Matthew
CENTRAL INDEX KEY: 0001816207
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39401
FILM NUMBER: 23776839
MAIL ADDRESS:
STREET 1: C/O ITEOS THERAPEUTICS, INC.
STREET 2: 139 MAIN STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: iTeos Therapeutics, Inc.
CENTRAL INDEX KEY: 0001808865
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 321 ARSENAL STREET
STREET 2: BLDG 312, FLOOR 3, SUITE 301
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 857-204-4583
MAIL ADDRESS:
STREET 1: 321 ARSENAL STREET
STREET 2: BLDG 312, FLOOR 3, SUITE 301
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-03-28
0
0001808865
iTeos Therapeutics, Inc.
ITOS
0001816207
Call Matthew
321 ARSENAL STREET
WATERTOWN
MA
02472
0
1
0
0
Chief Operating Officer
0
Common Stock
2023-03-28
4
M
0
40226
2.95
A
93898
D
Stock Option (right to buy)
2.95
2023-03-28
4
M
0
40226
0.00
D
2029-12-04
Common Stock
40226
107864
D
One-fourth of the shares subject to the stock option vest on the one-year anniversary of the vesting commencement date. Thereafter, 1/48 of the shares subject to the stock option vest on a monthly basis following the one-year anniversary of the vesting commencement date, subject to the reporting person's continuous service relationship with the Issuer through each applicable vesting date.
/s/ Adi Osovsky, as Attorney-in-Fact
2023-03-29